TYMS Antikörper (AA 265-294)
Kurzübersicht für TYMS Antikörper (AA 265-294) (ABIN7873043)
Target
Alle TYMS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 265-294
-
Verwendungszweck
- Thymidylate Synthase Antibody / TYSY
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 265-294 from the human protein was used as the immunogen for the Thymidylate Synthase Antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the Thymidylate Synthase antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Thymidylate Synthase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TYMS (Thymidylate Synthetase (TYMS))
-
Andere Bezeichnung
- Thymidylate Synthase
-
Hintergrund
- Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using 5,10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs.
-
UniProt
- P04818
-
Pathways
- Mitotic G1-G1/S Phases
Target
-